Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Anterix Inc.
13G/A
Amendment 1
ATEX · 03676C100
|
4.0% |
11/12/2025
Event 9/30/2025
|
|||
| DG Capital Management, LLC | 4.0% | ||||
| Dov Gertzulin | 4.0% | ||||
|
Anterix Inc.
13G
ATEX · 03676C100
|
5.2% |
8/14/2025
Event 6/30/2025
|
|||
| DG Capital Management, LLC | 5.2% | ||||
| Dov Gertzulin | 5.2% | ||||
|
Fennec Pharmaceuticals Inc.
13G/A
Amendment 2
FENC · 31447P100
|
4.1% |
2/14/2025
Event 12/31/2024
|
|||
| DG Capital Management, LLC | 4.1% | ||||
| DG Value Partners II Master Fund, LP | 3.5% | ||||
| Dov Gertzulin | 4.1% | ||||